[
    {
        "Materials Name": "ZIF-8",
        "Material Category": "MOFs",
        "Pore/Structural Features": {
            "Pore Size": "1.7 nm (microporous)",
            "Structure Type": "Not Reported"
        },
        "Topology": "Not Reported",
        "Metal Nodes": [
            "Zn2+"
        ],
        "Ligands": [
            "2-methylimidazole"
        ],
        "Guest Molecules": [
            {
                "Molecule Name": "curcumin",
                "Molecular Size": "Not Reported",
                "Can Pass Sieving": "Yes",
                "Mechanism": "Acid-sensitive dissolution of ZIF-8 shell",
                "Other Information": {
                    "Test Conditions": "pH 5.0, 37 °C",
                    "Threshold Pressure": "Not Applicable",
                    "Additional Info": "CUR was preferentially released to inhibit P-gp related drug efflux."
                }
            },
            {
                "Molecule Name": "doxorubicin",
                "Molecular Size": "Not Reported",
                "Can Pass Sieving": "Conditional (see Additional Info)",
                "Mechanism": "Sustained release from core after CUR release",
                "Other Information": {
                    "Test Conditions": "pH 5.0, 37 °C",
                    "Threshold Pressure": "Not Applicable",
                    "Additional Info": "DOX is released slower than CUR, achieving sequential delivery."
                }
            }
        ],
        "Sieving Mechanism": "Molecular sieving effects from CUR-loaded ZIF-8 coating",
        "Separation Mechanism": "molecular-sieving",
        "Experimental Validation": {
            "Method": "UV-vis absorbance and fluorescence spectrophotometry",
            "Performance Metrics": "61% CUR released in 0.5 h at pH 5.0; 40% DOX released in 32 h at pH 5.0"
        },
        "Other Information": {
            "Additional Info": "ZIF-8 shell prevents premature release of DOX, enabling sequential drug delivery."
        }
    }
]